English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In the setup of breast cancer management, axillary lymph node clearance plays a role in staging and planning of adjuvant chemotherapy and local control of cancer. Harvesting minimum of 10 lymph nodes for histopathological analysis is cut off value to consider a 90% certainty of a true negative axillary lymph node after axillary clearance. Aim: To assess the adequacy of axillary lymph node clearance considering influence of tumor factor (size, site, grade, type, lymphovascular invasion and hormonal and HER 2-NEU receptor status). Method: Retrospective analysis of histopathological report included 117 patients underwent mastectomy and axillary lymph node clearance from January 2011 to July 2016 in professorial surgical unit teaching hospital Jaffna. The analysis assessed the adequacy of the axillary lymph node clearance considering the influence of tumor factor. Results: Adequate axillary lymph node clearance was done in 89.7% (105). None of considered factors showed significance influence (p<0.05) except tumor type. Conclusion: Unit achieved desirable adequacy in axillary lymph node clearance, clearance adequacy is not associated with considered tumor factors except tumor type.

ADEQUACY OF AXILLARY LYMPH NODE CLEARANCE IN BREAST CARCINOMA: ARE WE ACHIEVING THE RECOMMENDED STANDARDS?